Home > Healthcare > Medical Devices > Diagnostic Devices > comprehensive metabolic panel testing market
Get a free sample of Comprehensive Metabolic Panel Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Comprehensive Metabolic Panel Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The comprehensive metabolic panel testing industry is consolidated, with major players such as Quest Diagnostics, Sonic Healthcare, and others dominating the market. These companies are focused on continuous test type innovation to secure a significant market share. For instance, in December 2021, Sonic Healthcare acquired ProPath. Under the supervision of a group of top-tier medical experts and researchers, ProPath frequently diagnoses patients from 45 states in the U.S. and numerous other countries. Thus, such acquisitions enable the company to expand and build a larger customer base.
Some of the eminent market participants operating in the comprehensive metabolic panel testing industry include:
The global comprehensive metabolic panel testing industry was valued at USD 12.8 billion in 2022 and is estimated to account for USD 29.5 billion by 2032.
The glucose segment garnered USD 3.1 billion in 2022 and will continue to grow as it provides essential information about an individual's blood sugar levels and is an indicator of various metabolic disorders, including metabolic syndrome.
U.S. comprehensive metabolic panel testing market accounted for USD 4.9 billion in 2022 and is predicted to grow through 2032, primarily attributed to the annual increase in the demand for diagnostic tests, advanced healthcare infrastructure, and leadership in innovative medical practices.
Abbott Laboratories, Quest Diagnostics, Laboratory Corporation of America Holdings Limited, Sonic Healthcare, Unipath, SYNLAB International GmbH, ARUP Laboratories, Genoptix Inc., and Nova Medical among others.